Réduire le risque de récidive du cancer du sein RH+/HER2- au stade précoce

About This Event

Join this essential discussion on reducing the risk of breast cancer recurrence for early-stage, hormone receptor-positive and HER2-negative patients. Hear from leading experts, explore the latest research and treatment advancements, and learn practical strategies to optimize outcomes and support your patients.